Abbisko Cayman Limited logo

Abbisko Cayman Limited

HKEX:2256.HK

Overview | Financials
Company Name Abbisko Cayman Limited
Symbol 2256.HK
Currency HKD
Price 3.12
Market Cap 2,118,220,185
Dividend Yield 0%
52-week-range 2.05 - 4.69
Industry Biotechnology
Sector Healthcare
CEO Dr. Yao-Chang Xu
Website https://www.abbisko.com

An error occurred while fetching data.

About Abbisko Cayman Limited

Abbisko Cayman Limited, a clinical-stage biopharmaceutical company, discovers and develops small molecule oncology therapies in the People's Republic of China. Its product candidates are primarily small molecules that focus on small molecule precision oncology and small molecule immuno-oncology therapeutic areas. The company's primary product candidates are ABSK011, a small molecule

Related Stocks

IntelliCentrics Global Holdings Ltd. logo

IntelliCentrics Global Holdings Ltd.

6819.HK

4.06 HKD

Modern Dental Group Limited logo

Modern Dental Group Limited

3600.HK

3.85 HKD

IVD Medical Holding Limited logo

IVD Medical Holding Limited

1931.HK

1.8 HKD

HBM Holdings Limited logo

HBM Holdings Limited

2142.HK

1.24 HKD

Immunotech Biopharm Ltd logo

Immunotech Biopharm Ltd

6978.HK

2.84 HKD

JW (Cayman) Therapeutics Co. Ltd logo

JW (Cayman) Therapeutics Co. Ltd

2126.HK

1.37 HKD

Mabpharm Limited logo

Mabpharm Limited

2181.HK

0.305 HKD

Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc.

9960.HK

1.22 HKD

Zhaoke Ophthalmology Limited logo

Zhaoke Ophthalmology Limited

6622.HK

1.37 HKD

China Pioneer Pharma Holdings Limited logo

China Pioneer Pharma Holdings Limited

1345.HK

2.08 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD